About Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals is a Healthcare company based in Lincoln (United States) founded in 2012. Proprietary chemistry for pharmaceutical synthesis is developed by the company. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Radioisotopes. Its competitors include NorthStar Medical Radioisotopes, Niowave and AZI; 3 of its 3 listed competitors have raised funding.
Company details
Ground Fluor Pharmaceuticals was founded in 2012 in Lincoln, United States, within the biomedical sector. Proprietary chemistry is developed for synthesizing pharmaceutical compounds, particularly Fluorine F-18 agents used in positron emission tomography imaging. The SWIFT platform technology, known as Swift Iodonium Fluorine Tagging, enables production of F18 radiopharmaceuticals with higher yields, potency, and reliability compared to existing methods. Pipeline products encompass 18F-m-Fluorobenzylguanidine, 18F-FPEB, 6-18F-Fluoro-L-DOPA, and 6-18F-Fluorophenylalanine.
- Headquarters Lincoln, United States
- SectorsHealthcare
- Email••••••••
- Website gfpharma.com
- InvestorsAmerica’s Seed Fund
& 1 more
Funding Insights of Ground Fluor Pharmaceuticals
- Total Rounds 5
- First Round $150,000
(Jun 2012)
- Investors Count 2
All 5 funding rounds of Ground Fluor Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2014 | Series A | – | – | – | |
| Apr 2014 | $1.36M | Grant | – | – | |
| Apr 2014 | $726,000 | Grant | – | – | |
| Jul 2012 | $180,000 | Grant | – | – | |
| Jun 2012 | $150,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include America’s Seed Fund and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Ground Fluor Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ground Fluor Pharmaceuticals
3 dated milestones of Ground Fluor Pharmaceuticals across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Ground Fluor Pharmaceuticals is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Series A,.
Competitors of Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include NorthStar Medical Radioisotopes, Niowave and AZI.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| northstarnm.com | 2006 | Madison, United States | $15.09M | Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market | ||
| niowaveinc.com | 2006 | United States | $9.95M | Devices and radioisotopes for nuclear imaging are provided by Niowave. | ||
| azisotopes.org | 2017 | Bunker Hill, United States | $58.33M | Radiopharmaceuticals for diagnostic imaging are developed and produced. |
Detailed competitors of Ground Fluor Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Ground Fluor Pharmaceuticals (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ground Fluor Pharmaceuticals
Complete news archive for Ground Fluor Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ground Fluor Pharmaceuticals
Ground Fluor Pharmaceuticals was founded in 2012.
Ground Fluor Pharmaceuticals is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.
Ground Fluor Pharmaceuticals was founded in 2012 in Lincoln, United States, within the biomedical sector. Proprietary chemistry is developed for synthesizing pharmaceutical compounds, particularly Fluorine F-18 agents used in positron emission tomography imaging. The SWIFT platform technology, known as Swift Iodonium Fluorine Tagging, enables production of F18 radiopharmaceuticals with higher yields, potency, and reliability compared to existing methods. Pipeline products encompass 18F-m-Fluorobenzylguanidine, 18F-FPEB, 6-18F-Fluoro-L-DOPA, and 6-18F-Fluorophenylalanine.
Ground Fluor Pharmaceuticals's top competitors include NorthStar Medical Radioisotopes, Niowave and AZI.
Ground Fluor Pharmaceuticals has 2 investors. Key investors include America’s Seed Fund, and National Science Foundation.